MetaVia Raises $8.1 Million Through Public Stock Offering for Cardiometabolic Innovation MetaVia Inc. announces its $8.1 million public offering aimed at funding the development of treatments for cardiometabolic diseases, including obesity.

MetaVia Raises $8.1 Million Through Public Stock Offering for Cardiometabolic Innovation #USA #Cambridge #MetaVia #DA-1726 #Series_C_Warrants